Switch to:
Also traded in: Brazil, Chile, Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.13
CVS's Cash-to-Debt is ranked lower than
96% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.12 vs. CVS: 0.13 )
Ranked among companies with meaningful Cash-to-Debt only.
CVS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.09  Med: 0.22 Max: 5.31
Current: 0.13
0.09
5.31
Equity-to-Asset 0.39
CVS's Equity-to-Asset is ranked higher than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.38 vs. CVS: 0.39 )
Ranked among companies with meaningful Equity-to-Asset only.
CVS' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.39  Med: 0.53 Max: 0.65
Current: 0.39
0.39
0.65
Interest Coverage 9.59
CVS's Interest Coverage is ranked higher than
50% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.59 vs. CVS: 9.59 )
Ranked among companies with meaningful Interest Coverage only.
CVS' s Interest Coverage Range Over the Past 10 Years
Min: 9.59  Med: 11.66 Max: 15.55
Current: 9.59
9.59
15.55
Piotroski F-Score: 5
Altman Z-Score: 3.70
Beneish M-Score: -2.63
WACC vs ROIC
5.31%
10.35%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 5.82
CVS's Operating Margin % is ranked higher than
65% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.07 vs. CVS: 5.82 )
Ranked among companies with meaningful Operating Margin % only.
CVS' s Operating Margin % Range Over the Past 10 Years
Min: 5.82  Med: 6.3 Max: 6.91
Current: 5.82
5.82
6.91
Net Margin % 3.00
CVS's Net Margin % is ranked higher than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.91 vs. CVS: 3.00 )
Ranked among companies with meaningful Net Margin % only.
CVS' s Net Margin % Range Over the Past 10 Years
Min: 3  Med: 3.44 Max: 3.74
Current: 3
3
3.74
ROE % 14.68
CVS's ROE % is ranked higher than
62% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.02 vs. CVS: 14.68 )
Ranked among companies with meaningful ROE % only.
CVS' s ROE % Range Over the Past 10 Years
Min: 9.14  Med: 11.33 Max: 14.68
Current: 14.68
9.14
14.68
ROA % 5.68
CVS's ROA % is ranked higher than
70% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.98 vs. CVS: 5.68 )
Ranked among companies with meaningful ROA % only.
CVS' s ROA % Range Over the Past 10 Years
Min: 5.46  Med: 5.99 Max: 7
Current: 5.68
5.46
7
ROC (Joel Greenblatt) % 68.55
CVS's ROC (Joel Greenblatt) % is ranked lower than
63% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 77.30 vs. CVS: 68.55 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CVS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 41.93  Med: 49.56 Max: 68.55
Current: 68.55
41.93
68.55
3-Year Revenue Growth Rate 16.70
CVS's 3-Year Revenue Growth Rate is ranked higher than
75% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. CVS: 16.70 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CVS' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -13.3  Med: 12.2 Max: 19.5
Current: 16.7
-13.3
19.5
3-Year EBITDA Growth Rate 11.80
CVS's 3-Year EBITDA Growth Rate is ranked higher than
58% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.60 vs. CVS: 11.80 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CVS' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -29.4  Med: 11.8 Max: 43.7
Current: 11.8
-29.4
43.7
3-Year EPS without NRI Growth Rate 9.40
CVS's 3-Year EPS without NRI Growth Rate is ranked higher than
56% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.30 vs. CVS: 9.40 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CVS' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -48.3  Med: 14.6 Max: 112.8
Current: 9.4
-48.3
112.8
GuruFocus has detected 1 Warning Sign with CVS Health Corp $CVS.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CVS's 10-Y Financials

Financials (Next Earnings Date: 2017-05-02)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

CVS Guru Trades in Q2 2016

Jerome Dodson 234,000 sh (New)
Ray Dalio 149,700 sh (New)
John Buckingham 43,573 sh (New)
Louis Moore Bacon 2,679 sh (New)
Paul Tudor Jones 33,167 sh (New)
Jim Simons 3,842,105 sh (+1869.25%)
Joel Greenblatt 652,002 sh (+196.03%)
George Soros 41,175 sh (+49.67%)
Robert Olstein 91,000 sh (+42.19%)
RS Investment Management 897,935 sh (+13.27%)
Murray Stahl 3,397 sh (+9.94%)
First Pacific Advisors 114,190 sh (+7.58%)
Pioneer Investments 5,751,921 sh (+7.25%)
Richard Pzena 529,884 sh (+0.23%)
Tom Gayner 247,000 sh (unchged)
Jeff Auxier 52,349 sh (unchged)
Mairs and Power 3,069 sh (unchged)
Westport Asset Management 192,090 sh (unchged)
Dodge & Cox Sold Out
Steven Cohen Sold Out
PRIMECAP Management 3,527,170 sh (-0.61%)
Manning & Napier Advisors, Inc 86,530 sh (-0.64%)
Charles de Vaulx 753,827 sh (-3.20%)
Mario Gabelli 1,139,978 sh (-4.11%)
Scott Black 17,206 sh (-5.20%)
Ruane Cunniff 14,856 sh (-7.04%)
Ken Fisher 129,783 sh (-8.81%)
NWQ Managers 607,584 sh (-14.13%)
Jeremy Grantham 1,825,963 sh (-21.26%)
» More
Q3 2016

CVS Guru Trades in Q3 2016

David Dreman 9,185 sh (New)
Barrow, Hanley, Mewhinney & Strauss 9,100,036 sh (New)
Steven Cohen 82,162 sh (New)
John Paulson 122,200 sh (New)
Eaton Vance Worldwide Health Sciences Fund 228,705 sh (New)
NWQ Managers 933,958 sh (+53.72%)
Scott Black 23,496 sh (+36.56%)
Robert Olstein 108,000 sh (+18.68%)
First Pacific Advisors 131,530 sh (+15.19%)
Jerome Dodson 256,000 sh (+9.40%)
Ken Fisher 132,741 sh (+2.28%)
Manning & Napier Advisors, Inc 87,010 sh (+0.55%)
Richard Pzena 529,858 sh (unchged)
Tom Gayner 247,000 sh (unchged)
George Soros 689,500 sh (unchged)
Ray Dalio Sold Out
Louis Moore Bacon Sold Out
George Soros Sold Out
Jeff Auxier 52,199 sh (-0.29%)
PRIMECAP Management 3,492,690 sh (-0.98%)
John Buckingham 42,964 sh (-1.40%)
Pioneer Investments 5,533,119 sh (-3.80%)
Mairs and Power 2,949 sh (-3.91%)
Murray Stahl 3,197 sh (-5.89%)
Mario Gabelli 1,065,457 sh (-6.54%)
Charles de Vaulx 703,490 sh (-6.68%)
Ruane Cunniff 13,801 sh (-7.10%)
Signature Select Canadian Fund 58,903 sh (-15.92%)
Joel Greenblatt 440,659 sh (-32.41%)
Jeremy Grantham 1,144,482 sh (-37.32%)
Jim Simons 940,005 sh (-75.53%)
Paul Tudor Jones 6,831 sh (-79.40%)
» More
Q4 2016

CVS Guru Trades in Q4 2016

Arnold Van Den Berg 69,740 sh (New)
Richard Snow 3,995 sh (New)
Ray Dalio 109,013 sh (New)
Wallace Weitz 121,162 sh (New)
John Rogers 33,499 sh (New)
Paul Tudor Jones 28,945 sh (+323.73%)
Joel Greenblatt 1,055,841 sh (+139.61%)
Manning & Napier Advisors, Inc 190,110 sh (+118.49%)
Barrow, Hanley, Mewhinney & Strauss 18,280,528 sh (+100.88%)
Charles de Vaulx 1,384,235 sh (+96.77%)
NWQ Managers 1,352,559 sh (+44.82%)
Pioneer Investments 7,679,466 sh (+38.79%)
Steven Cohen 112,900 sh (+37.41%)
Robert Olstein 140,000 sh (+29.63%)
First Pacific Advisors 161,800 sh (+23.01%)
Jeff Auxier 62,049 sh (+18.87%)
John Buckingham 45,261 sh (+5.35%)
Scott Black 24,241 sh (+3.17%)
Ken Fisher 134,917 sh (+1.64%)
Richard Pzena 533,748 sh (+0.73%)
Mario Gabelli 1,071,617 sh (+0.58%)
Tom Gayner 248,000 sh (+0.40%)
John Paulson Sold Out
Eaton Vance Worldwide Health Sciences Fund Sold Out
Jeremy Grantham 1,140,718 sh (-0.33%)
Mairs and Power 2,879 sh (-2.37%)
PRIMECAP Management 3,409,100 sh (-2.39%)
Ruane Cunniff 13,401 sh (-2.90%)
David Dreman 8,061 sh (-12.24%)
Murray Stahl 2,767 sh (-13.45%)
Jim Simons 724,505 sh (-22.93%)
Jerome Dodson 186,000 sh (-27.34%)
» More
Q1 2017

CVS Guru Trades in Q1 2017

Ken Fisher 263,189 sh (+95.07%)
Arnold Van Den Berg 68,655 sh (-1.56%)
Manning & Napier Advisors, Inc 141,680 sh (-25.47%)
Jerome Dodson 106,000 sh (-43.01%)
» More
» Details

Insider Trades

Latest Guru Trades with CVS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans    NAICS: 621399    SIC: 8099
Compare:NYSE:AET, NAS:ESRX, NYSE:CI, NYSE:HUM, NYSE:ANTX, NYSE:CNC, NYSE:UNH, NYSE:WCG, NYSE:MOH, OTCPK:ODPVY, NAS:MGLN, NYSE:UAM, NAS:HIIQ, OTCPK:WCUI, OTCPK:OPRX, NAS:CNXR » details
Traded in other countries:CVSH34.Brazil, CVS.Chile, CVS.Germany, CVS.Mexico,
Headquarter Location:USA
CVS Health Corp iis an integrated pharmacy health care provider. The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate.

CVS Health combines one of the largest retail pharmacy chains in the United States with one of the largest pharmacy benefit managers. The company processes approximately 1.3 billion prescriptions per year and operates more than 10,000 retail pharmacies across the U.S.

Guru Investment Theses on CVS Health Corp

Weitz Funds Comments on CVS Health - Jan 26, 2017

CVS Health (NYSE:CVS) operates a nationwide network of nearly 10,000 retail pharmacies, the nation’s second largest pharmacy benefits manager (PBM) in Caremark, and sizeable specialty and long-term care pharmacy platforms. This is the fund’s second go around with CVS, having last owned it back in 2013. CVS’ stock has been under pressure for most of the last 18 months after peaking during the summer of 2015. After nearly five years of consistent market share gains, the Caremark PBM suffered several client losses over the course of 2016. In addition, CVS also announced that its retail pharmacies would no longer be part of several important networks in 2017. These lost volumes will likely result in no earnings per share growth this year. These near-term negatives drove the stock down to a price that we found attractive. While management will need to navigate several risks over the course of the next couple of years, we believe CVS’ stock price provides an attractive valuation in the mid-$70s.



  • From Weitz Investment Management's Value Fund 4th quarter 2016 commentary.


Check out Wallace Weitz latest stock trades

Mario Gabelli Comments on CVS Health Corp - Nov 02, 2016

CVS Health Corp. (NYSE:CVS) (2.3%) (CVS – $88.99 – NYSE) is the leading pharmacy and pharmacy benefits manager in the country, with over $150 billion in annual revenue. The stock declined in the quarter due to the significant political scrutiny around drug pricing. Efforts to regulate and control drug pricing could have an indirect impact on CVS’s revenues and earnings. However, we believe the company is a low cost provider who already works aggressively to improve health through the dispensing of low cost generic drugs, coordination of care, and efforts to improve adherence by patients.



From Mario Gabelli (Trades, Portfolio)'s Equity Income Fund 3rd quarter 2016 commentary.

Check out Mario Gabelli latest stock trades

Mario Gabelli Comments on CVS Health Corp - Feb 05, 2016

CVS Health Corp. (2.4%) (CVS – $97.77 – NYSE)(NYSE:CVS) is the leading pharmacy and pharmacy benefits manager in the country, with over $150 billion in annual revenue. The company’s recent acquisitions of institutional pharmacy Omnicare and the pharmacies inside Target stores should add $0.15 to earnings in 2016 and further CVS’s dominance across the pharmacy channel. Same store sales should improve in 2016 now that the company has annualized its decision to stop selling tobacco, and that decision has helped them win over $11 billion in net new business for its pharmacy benefits management (PBM) division.

From Mario Gabelli (Trades, Portfolio)'s GAMCO Equity Income Fund fourth quarter 2015 commentary.

Check out Mario Gabelli latest stock trades

Top Ranked Articles about CVS Health Corp

Weitz Funds Comments on CVS Health Guru stock highlight
CVS Health (NYSE:CVS) operates a nationwide network of nearly 10,000 retail pharmacies, the nation’s second largest pharmacy benefits manager (PBM) in Caremark, and sizeable specialty and long-term care pharmacy platforms. This is the fund’s second go around with CVS, having last owned it back in 2013. CVS’ stock has been under pressure for most of the last 18 months after peaking during the summer of 2015. After nearly five years of consistent market share gains, the Caremark PBM suffered several client losses over the course of 2016. In addition, CVS also announced that its retail pharmacies would no longer be part of several important networks in 2017. These lost volumes will likely result in no earnings per share growth this year. These near-term negatives drove the stock down to a price that we found attractive. While management will need to navigate several risks over the course of the next couple of years, we believe CVS’ stock price provides an attractive valuation in the mid-$70s. Read more...
Does the Increase in Volatility Signal a Dangerous Market Environment? Anxiety typically leads to knee-jerk reactions and excessive trading in their portfolios
Over the last several weeks stock price volatility has increased significantly above norms. All of a sudden it is not uncommon to see stock prices moving 5%, 10% or more in a single trading day. Interestingly, this volatility is occurring both to the upside and the downside. Common sense would suggest that the intrinsic value of a business cannot change by those orders of magnitude from one day to the next. Logic dictates that the market is either inaccurately pricing the stocks now or it was incorrectly pricing them the day before. Read more...
Robert Olstein Continues to Buy eBay, Walt Disney Stocks the investor bought for the past 2 quarters
Robert Olstein (Trades, Portfolio) is the chairman and chief investment officer of the Olstein Financial Alert Fund. In both the second and third quarters the guru bought shares in the following stocks: Read more...
Mario Gabelli Comments on CVS Health Corp Guru stock highlight
CVS Health Corp. (NYSE:CVS) (2.3%) (CVS – $88.99 – NYSE) is the leading pharmacy and pharmacy benefits manager in the country, with over $150 billion in annual revenue. The stock declined in the quarter due to the significant political scrutiny around drug pricing. Efforts to regulate and control drug pricing could have an indirect impact on CVS’s revenues and earnings. However, we believe the company is a low cost provider who already works aggressively to improve health through the dispensing of low cost generic drugs, coordination of care, and efforts to improve adherence by patients. Read more...
Jim Simons Ups Stake in CVS Health Company is largest health care provider in US
During the second quarter, guru Jim Simons (Trades, Portfolio), the founder of the hedge fund Renaissance Technologies, added to his stake in CVS Health Corp. (CVS) by adding an additional 3,647,000 shares of the company to his portfolio. Simons now owns 3,842,105 shares of CVS Health Corp. Read more...
Ray Dalio's 5 Biggest 2nd-Quarter New Stock Buys Dalio bought Johnson & Johnson, CVS and more
Ray Dalio (Trades, Portfolio) manages the $150 billion Westport, Connecticut-based hedge fund Bridgewater Associates, the largest hedge fund firm in the world. The equity portfolio at Bridgewater has a total value of only $7.98 billion. According to filings disclosed Thursday, Dalio added 139 new positions to it in the second quarter. Read more...
Jerome Dodson Goes 3 for 3 in Second Quarter Dodson gains 3 new holdings, sells 3
Investor Jerome Dodson (Trades, Portfolio) of the Parnassus Fund gained three new holdings and sold out three holdings during the second quarter. Read more...
Stocks Manning & Napier Continues Buying Firm has been investing in these companies for the last 2 quarters
Manning & Napier Advisors Inc. was founded in April 1970 by Bill Manning and Bill Napier. It manages a portfolio composed of 325 stocks, several of which have been bought for the last two quarters. Read more...
Pioneer Investments Adds to Stake in CVS Company has 53 years of experience with over $150 billion in annual revenue
Pioneer Investments (Trades, Portfolio) was founded by Philip L. Carret in 1928. Carret started his own investment portfolio with $10,000. Over the course of the next 55 years, his initial investment grew to $8 million. Warren Buffett (Trades, Portfolio) once said that Carret had "the best long term investment record of anyone I know." Read more...

Ratios

vs
industry
vs
history
PE Ratio 16.69
CVS's PE Ratio is ranked higher than
70% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 20.35 vs. CVS: 16.69 )
Ranked among companies with meaningful PE Ratio only.
CVS' s PE Ratio Range Over the Past 10 Years
Min: 10.58  Med: 17.77 Max: 27.17
Current: 16.69
10.58
27.17
Forward PE Ratio 14.03
CVS's Forward PE Ratio is ranked higher than
72% of the 36 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.62 vs. CVS: 14.03 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 16.65
CVS's PE Ratio without NRI is ranked higher than
70% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.38 vs. CVS: 16.65 )
Ranked among companies with meaningful PE Ratio without NRI only.
CVS' s PE Ratio without NRI Range Over the Past 10 Years
Min: 10.62  Med: 17.66 Max: 27.17
Current: 16.65
10.62
27.17
Price-to-Owner-Earnings 12.08
CVS's Price-to-Owner-Earnings is ranked higher than
50% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.58 vs. CVS: 12.08 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CVS' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 9.08  Med: 20.38 Max: 60.4
Current: 12.08
9.08
60.4
PB Ratio 2.37
CVS's PB Ratio is ranked higher than
70% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.55 vs. CVS: 2.37 )
Ranked among companies with meaningful PB Ratio only.
CVS' s PB Ratio Range Over the Past 10 Years
Min: 1.01  Med: 1.79 Max: 3.37
Current: 2.37
1.01
3.37
PS Ratio 0.50
CVS's PS Ratio is ranked higher than
70% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.57 vs. CVS: 0.50 )
Ranked among companies with meaningful PS Ratio only.
CVS' s PS Ratio Range Over the Past 10 Years
Min: 0.4  Med: 0.59 Max: 0.89
Current: 0.5
0.4
0.89
Price-to-Free-Cash-Flow 11.28
CVS's Price-to-Free-Cash-Flow is ranked higher than
63% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.11 vs. CVS: 11.28 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CVS' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 8.96  Med: 20.73 Max: 105.03
Current: 11.28
8.96
105.03
Price-to-Operating-Cash-Flow 8.80
CVS's Price-to-Operating-Cash-Flow is ranked higher than
76% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.41 vs. CVS: 8.80 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CVS' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 6.72  Med: 12.7 Max: 19.27
Current: 8.8
6.72
19.27
EV-to-EBIT 10.84
CVS's EV-to-EBIT is ranked higher than
53% of the 43 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.77 vs. CVS: 10.84 )
Ranked among companies with meaningful EV-to-EBIT only.
CVS' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.6  Med: 11.3 Max: 20.3
Current: 10.84
7.6
20.3
EV-to-EBITDA 8.63
CVS's EV-to-EBITDA is ranked lower than
53% of the 45 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.48 vs. CVS: 8.63 )
Ranked among companies with meaningful EV-to-EBITDA only.
CVS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.2  Med: 9.1 Max: 16
Current: 8.63
6.2
16
PEG Ratio 1.18
CVS's PEG Ratio is ranked higher than
71% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.87 vs. CVS: 1.18 )
Ranked among companies with meaningful PEG Ratio only.
CVS' s PEG Ratio Range Over the Past 10 Years
Min: 0.55  Med: 1.29 Max: 2.48
Current: 1.18
0.55
2.48
Shiller PE Ratio 24.06
CVS's Shiller PE Ratio is ranked higher than
69% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 25.26 vs. CVS: 24.06 )
Ranked among companies with meaningful Shiller PE Ratio only.
CVS' s Shiller PE Ratio Range Over the Past 10 Years
Min: 17.19  Med: 26.06 Max: 39.08
Current: 24.06
17.19
39.08
Current Ratio 1.18
CVS's Current Ratio is ranked lower than
53% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.21 vs. CVS: 1.18 )
Ranked among companies with meaningful Current Ratio only.
CVS' s Current Ratio Range Over the Past 10 Years
Min: 1.18  Med: 1.62 Max: 2.62
Current: 1.18
1.18
2.62
Quick Ratio 0.62
CVS's Quick Ratio is ranked lower than
84% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.15 vs. CVS: 0.62 )
Ranked among companies with meaningful Quick Ratio only.
CVS' s Quick Ratio Range Over the Past 10 Years
Min: 0.31  Med: 0.58 Max: 0.93
Current: 0.62
0.31
0.93
Days Inventory 34.96
CVS's Days Inventory is ranked lower than
71% of the 7 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.72 vs. CVS: 34.96 )
Ranked among companies with meaningful Days Inventory only.
CVS' s Days Inventory Range Over the Past 10 Years
Min: 34.96  Med: 41.19 Max: 50.42
Current: 34.96
34.96
50.42
Days Sales Outstanding 25.01
CVS's Days Sales Outstanding is ranked higher than
50% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 25.01 vs. CVS: 25.01 )
Ranked among companies with meaningful Days Sales Outstanding only.
CVS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 18.65  Med: 22.19 Max: 28.31
Current: 25.01
18.65
28.31
Days Payable 19.51
CVS's Days Payable is ranked lower than
67% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 42.29 vs. CVS: 19.51 )
Ranked among companies with meaningful Days Payable only.
CVS' s Days Payable Range Over the Past 10 Years
Min: 16.58  Med: 19.59 Max: 21.78
Current: 19.51
16.58
21.78

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 2.25
CVS's Dividend Yield % is ranked higher than
77% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.29 vs. CVS: 2.25 )
Ranked among companies with meaningful Dividend Yield % only.
CVS' s Dividend Yield % Range Over the Past 10 Years
Min: 0.42  Med: 1.15 Max: 2.27
Current: 2.25
0.42
2.27
Dividend Payout Ratio 0.35
CVS's Dividend Payout Ratio is ranked lower than
69% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.33 vs. CVS: 0.35 )
Ranked among companies with meaningful Dividend Payout Ratio only.
CVS' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.11  Med: 0.2 Max: 0.35
Current: 0.35
0.11
0.35
3-Year Dividend Growth Rate 23.60
CVS's 3-Year Dividend Growth Rate is ranked higher than
75% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.70 vs. CVS: 23.60 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
CVS' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -33.8  Med: 8 Max: 37
Current: 23.6
-33.8
37
Forward Dividend Yield % 2.43
CVS's Forward Dividend Yield % is ranked higher than
76% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.52 vs. CVS: 2.43 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 7.70
CVS's 5-Year Yield-on-Cost % is ranked higher than
79% of the 34 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.08 vs. CVS: 7.70 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
CVS' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.44  Med: 3.94 Max: 7.77
Current: 7.7
1.44
7.77
3-Year Average Share Buyback Ratio 3.50
CVS's 3-Year Average Share Buyback Ratio is ranked higher than
72% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.00 vs. CVS: 3.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CVS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -22.9  Med: -0.1 Max: 7
Current: 3.5
-22.9
7

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 0.81
CVS's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
75% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.01 vs. CVS: 0.81 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CVS' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.64  Med: 1.3 Max: 18.84
Current: 0.81
0.64
18.84
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.04
CVS's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
82% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.39 vs. CVS: 1.04 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 0.85
CVS's Price-to-Median-PS-Value is ranked higher than
67% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.91 vs. CVS: 0.85 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CVS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.42  Med: 0.9 Max: 2.51
Current: 0.85
0.42
2.51
Price-to-Peter-Lynch-Fair-Value 1.22
CVS's Price-to-Peter-Lynch-Fair-Value is ranked higher than
64% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.50 vs. CVS: 1.22 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
CVS' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.64  Med: 1.52 Max: 3.95
Current: 1.22
0.64
3.95
Earnings Yield (Greenblatt) % 9.23
CVS's Earnings Yield (Greenblatt) % is ranked higher than
52% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.29 vs. CVS: 9.23 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CVS' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 4.9  Med: 8.8 Max: 13.1
Current: 9.23
4.9
13.1
Forward Rate of Return (Yacktman) % 19.32
CVS's Forward Rate of Return (Yacktman) % is ranked higher than
67% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.81 vs. CVS: 19.32 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CVS' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 11.3  Med: 18 Max: 24.2
Current: 19.32
11.3
24.2

More Statistics

Revenue (TTM) (Mil) $177,526
EPS (TTM) $ 4.91
Beta0.67
Short Percentage of Float2.32%
52-Week Range $69.30 - 106.67
Shares Outstanding (Mil)1,035.79

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 184,025 195,120 204,053
EPS ($) 5.74 6.33 6.79
EPS without NRI ($) 5.74 6.33 6.79
EPS Growth Rate
(Future 3Y To 5Y Estimate)
14.69%
Dividends per Share ($) 1.94 2.20 2.91
» More Articles for CVS

Headlines

Articles On GuruFocus.com
Tariff Threat Could Be to Blame for Brick-and-Mortar Retailers Closing at Record Pace Apr 24 2017 
CVS Health Corporation To Hold First Quarter 2017 Conference Call Apr 21 2017 
CVS Pharmacy Unveils Enhanced Customer Experience, New Store Design Apr 20 2017 
Covered Call reports for Apple, Bank of America, Cardinal Health, CVS Health Corp., and Walgreens Bo Apr 19 2017 
Phoenix VA Health Care System, TriWest, and CVS Health Partner to Increase Veteran Access to Health Apr 18 2017 
CVS Health Expands Its Policy and External Affairs Team; Bolsters Presence in D.C. and State Capital Apr 06 2017 
Billion Dollar Roundtable Recognizes CVS Health for Reaching $1 Billion in Diverse Supplier Spending Apr 05 2017 
CVS Health's Advanced Care Scripts (ACS) Earns URAC Accreditation for Specialty Pharmacy Apr 04 2017 
High return options reports for Alcoa, CVS Health Corp, Lululemon, Unilever, WPX Energy, and many mo Mar 31 2017 
CVS Pharmacy® Makes Korean Beauty More Accessible Than Ever Mar 31 2017 

More From Other Websites
[$$] Express Scripts Faces a Future Without Its Biggest Customer Apr 25 2017
[$$] CVS Move Hurts Hershey, Boosts Post, Mondelez Apr 25 2017
Rite Aid Finally Gets Some Good News As Walgreens Deal In Doubt Apr 25 2017
The Long-Term Trend That Makes CVS Health an Awesome Buy Apr 25 2017
3 Stocks Could Double Their Dividends -- But Shouldn't Apr 25 2017
CVS Health Corp. – Value Analysis (NYSE:CVS) : April 24, 2017 Apr 24 2017
Can CVS Health (CVS) Spring a Surprise this Earnings Season? Apr 24 2017
3 Top Stocks for Retirees Apr 23 2017
Can CVS Become The Whole Foods Of Drugstore Retailing? Apr 22 2017
3 Great Income Stocks That Could Double Their Dividends Apr 21 2017
CVS Health Corporation To Hold First Quarter 2017 Conference Call Apr 21 2017
20 Large Retailers Besides J.C. Penney Are Closing Waves of Stores Apr 21 2017
CVS Health Corp. breached its 50 day moving average in a Bullish Manner : CVS-US : April 21, 2017 Apr 21 2017
GMAC Commercial Mortgage Securities, Inc. 1999-C2 -- Moody's Affirms Three and Upgrades Two Classes... Apr 20 2017
Cherokee Nation sues opioid wholesalers, retailers for abuse Apr 20 2017
Today's charts: Wal-Mart, Kroger price wars; Apple shares gain; JPMorgan upgrades Gap; CVS cuts... Apr 20 2017
Today's charts: Wal-Mart, Kroger price wars; Apple shares climb; Gap gets upgraded; CVS cuts... Apr 20 2017
CVS Health Corp. : CVS-US: Dividend Analysis : April 21st, 2017 (record date) : By the numbers :... Apr 20 2017
CVS unveils new store design, removing certain chemicals from beauty products Apr 20 2017
CVS Pharmacy Unveils Enhanced Customer Experience, New Store Design Apr 20 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)